Oral Anticoagulation Use in High Risk Patients Is Improved by Elimination of False Positive and Inactive Atrial Fibrillation Cases

Multiple registries have reported that greater than 40% of high-risk atrial fibrillation patients are not taking oral anticoagulants. The purpose of our study was to determine the presence or absence of active atrial fibrillation and CHA2DS2VASc risk factors to accurately identify high-risk atrial fibrillation (CHA2DS2VASc ≥ 2) patients requiring oral anticoagulants and the magnitude of the anticoagulant treatment gap.

Source: The American Journal of Medicine - December 23, 2020 Category: General Medicine Authors: Gerald V. Naccarelli, Mohammed Ruzieh, Deborah L. Wolbrette, Mauricio Sendra-Ferrer, John van Harskamp, Barbara Bentz, Gregory Caputo, Nathan McConkey, Kevin Mills, Stephen Wasemiller, Jovan Plamenac, Douglas Leslie, Frendy D. Glasser, Thomas W. Abendroth Tags: Clinical Research Study Source Type: research